Abstract
This work presents the measurements of proton activation of a group of 15 patients following proton radiotherapy of the eye. Despite the heterogeneity in activation response and reaction cross section compared with the applied uniform dose, it can be shown that induced activity may be related to incident fluence volume and thus provide verification of applied dose. This proton treatment provides in vivo information that is normally unused. Up to 400 kBq was measured at 100-second post-treatment. Significant correlation of the 15O 511 keV activity with fluence volume is shown. The patient γ-ray spectra are tabulated and discussed. The longer-lived 7Be (T 1/2 = 53.1 d) activity, from O and C activation, may provide an additional means of dose verification. The potential of (p,p’γ) reactions was examined by irradiation of phantoms. High energy γ-rays from O and C were measured with a large NaI(Tl) detector, with a yield of 125 γ/cm2/mGy for the 16O(p,p’γ) reaction.
Similar content being viewed by others
References
K. Ulin, R. G. Zamenhof, Med. Phys., 13 (1986) 887.
G. W. Bennett, J. O. Archambeau, B. E. Archambeau, J. I. Meltzer, C. L. Wingate, Science, 200 (1978) 1151.
S. Vynckier, S. Derreumaux, F. Richard, A. Bol, C. Michel, A. Wambersie, Is it possible to verify directly a proton-treatment plan using positron tomography? Radiother. Oncol., 26 (1993) 275.
V. Kostjuchenko, D. Nichiporov, E. Grussell, Determination of the absorbed dose from the flux measurement: Potentialities of the Faraday cup and activation methods, Particle Therapy Cooperative Group Meeting, PTCOG XXIV, program and abstracts, Detroit, Michigan, USA, April 24–26, 1996, p. 47.
W. Enghardt, J. Debus, T. Haberer, B. G. Hasch, R. Hinz, O. Jakel, M. Kramer, K. Lauckner, J. Pawelke, F. Ponisch, Nucl. Phys., A654 (1999) 1047.
K. Parodi, W. Enghardt, Phys. Med. Biol., 45 (2000) N151.
U. Oelfke, G. K. Y. Lam, M. S. Atkins, Phys. Med. Biol., 41 (1996) 177.
A. Del Guerra, G. Di Domenico, M. Gambaccini, M. Marziani, Nucl. Instr. Meth., A345 (1994) 370.
R. F. Eilbert, A. M. Koehler, J. M. Sisterson, R. Wilson, S. J. Adelstein, Phys. Med. Biol., 22 (1977) 817.
D. E. Bonnett, A. Kacperek, M. A. Sheen, R. Goodall, T. E. Saxton, British J. Radiol., 66 (1993) 907.
Particles Newsletter (Proton Therapy Co-operative Group), on http://ptcog.mgh.harvard.edu/, Northeast Proton Therapy Center, Massachusetts General Hospital, Boston, MA, 02114 USA.
IAEA Nuclear Data Centre, 2004, http://www-nds.iaea.or.at/exfor/
ICRP Publication 23, Report on the Task Group on Reference Man, Pergamon Press, 1975.
ICRU Report 44, Tissue Substitutes in Radiation Dosimetry and Measurement, January, 1989, Maryland, 20814, USA.
S. Y. F. Chu, L. P. Ekström, R. B. Firestone, The Lund/LBNL Nuclear Data Search, Version 2.0, February 1999, http://nucleardata.nuclear.lu.se/NuclearData/toi
J. M. Sisterson, R. J. Schneider, P. H. Tibbetts, M. D. Grynpas, L. C. Bonar, J. Radioanal. Chem., 71 (1982) 509.
J. Beebe-Wang, P. Vaska, F. A. Dilmanian, S. G. Peggs, D. J. Schlyer, Simulation of Proton Therapy Verification via PET imaging of Induced Positron-Emitters, C-A/AP/#122, IEEE Nuclear Science Symposium/Medical Imaging Conf., November, 2003.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kacperek, A. Dose verification by activation in vivo following proton beam eye radiotherapy. J Radioanal Nucl Chem 271, 731–740 (2007). https://doi.org/10.1007/s10967-007-0334-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10967-007-0334-7